These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38190394)

  • 1. What risk do Brucella vaccines pose to humans? A systematic review of the scientific literature on occupational exposure.
    Vives-Soto M; Puerta-García A; Rodríguez-Sánchez E; Pereira JL; Solera J
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011889. PubMed ID: 38190394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
    Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
    Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accidental exposure to Brucella abortus vaccines and occupational brucellosis among veterinarians in Minas Gerais state, Brazil.
    Pereira CR; de Oliveira IRC; de Oliveira LF; de Oliveira CSF; Lage AP; Dorneles EMS
    Transbound Emerg Dis; 2021 May; 68(3):1363-1376. PubMed ID: 32810924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates.
    Todd TE; Tibi O; Lin Y; Sayers S; Bronner DN; Xiang Z; He Y
    BMC Bioinformatics; 2013; 14 Suppl 6(Suppl 6):S3. PubMed ID: 23735014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational exposure to Brucella spp.: A systematic review and meta-analysis.
    Pereira CR; Cotrim de Almeida JVF; Cardoso de Oliveira IR; Faria de Oliveira L; Pereira LJ; Zangerônimo MG; Lage AP; Dorneles EMS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008164. PubMed ID: 32392223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of occupational
    Zhou C; Huang W; Xiang X; Qiu J; Xiao D; Yao N; Shu Q; Zhou S
    Emerg Microbes Infect; 2022 Dec; 11(1):2544-2552. PubMed ID: 36178040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brucellosis vaccines for livestock.
    Goodwin ZI; Pascual DW
    Vet Immunol Immunopathol; 2016 Nov; 181():51-58. PubMed ID: 27032465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.
    Wallach JC; Ferrero MC; Victoria Delpino M; Fossati CA; Baldi PC
    Clin Microbiol Infect; 2008 Aug; 14(8):805-7. PubMed ID: 18727806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in livestock and wildlife brucellosis vaccination.
    Olsen SC
    Rev Sci Tech; 2013 Apr; 32(1):207-17. PubMed ID: 23837378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of vaccines in brucellosis control and eradication programs for livestock.
    Olsen SC; Stoffregen WS
    Expert Rev Vaccines; 2005 Dec; 4(6):915-28. PubMed ID: 16372886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination control programs for multiple livestock host species: an age-stratified, seasonal transmission model for brucellosis control in endemic settings.
    Beauvais W; Musallam I; Guitian J
    Parasit Vectors; 2016 Jan; 9():55. PubMed ID: 26825313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immune responses to
    Darbandi A; Alamdary SZ; Koupaei M; Ghanavati R; Heidary M; Talebi M
    Front Vet Sci; 2022; 9():903890. PubMed ID: 36118342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis and Advancement of Brucellosis Vaccinology.
    Carvalho TF; Haddad JP; Paixão TA; Santos RL
    PLoS One; 2016; 11(11):e0166582. PubMed ID: 27846274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
    Wang H; Hoffman C; Yang X; Clapp B; Pascual DW
    PLoS Pathog; 2020 Jan; 16(1):e1008176. PubMed ID: 31951645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.